{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:50:19Z","timestamp":1740142219191,"version":"3.37.3"},"reference-count":106,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/501100003329","name":"Spanish Ministry of Economy and Competitiveness","doi-asserted-by":"publisher","award":["CTQ2017-87637-R"],"award-info":[{"award-number":["CTQ2017-87637-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2020,3,9]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Positron Emission Tomography (PET) and Single Photon Emission Computerized Tomography\n(SPECT) are ultra-sensitive, fully translational and minimally invasive nuclear imaging techniques\ncapable of tracing the spatiotemporal distribution of positron (PET) or gamma (SPECT) emitter-labeled\nmolecules after administration into a living organism. Besides their impact in the clinical diagnostic, PET\nand SPECT are playing an increasing role in the process of drug development, both during the evaluation\nof the pharmacokinetic properties of new chemical entities as well as in the proof of concept, proof of\nmechanism and proof of efficacy studies. However, they have been scarcely applied in the context of\nophthalmic drugs. In this paper, the basics of nuclear imaging and radiochemistry are briefly discussed,\nand the few examples of the use of these imaging modalities in ophthalmic drug development reported in\nthe literature are presented and discussed. Finally, in a purely theoretical exercise, some labeling strategies\nthat could be applied to the preparation of selected ophthalmic drugs are proposed and potential applications\nof nuclear imaging in ophthalmology are projected.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867326666190530122032","type":"journal-article","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T20:43:13Z","timestamp":1559248993000},"page":"501-522","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Radiochemistry: A Useful Tool in the Ophthalmic Drug Discovery"],"prefix":"10.2174","volume":"27","author":[{"given":"Krishna R.","family":"Pulagam","sequence":"first","affiliation":[{"name":"Radiochemistry and Nuclear Imaging Group, CIC biomaGUNE, San Sebastian, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"G\u00f3mez-Vallejo","sequence":"additional","affiliation":[{"name":"Radiochemistry Platform, CIC biomaGUNE, San Sebastian, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Llop","sequence":"additional","affiliation":[{"name":"Radiochemistry and Nuclear Imaging Group, CIC biomaGUNE, San Sebastian, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luka","family":"Rejc","sequence":"additional","affiliation":[{"name":"Radiochemistry and Nuclear Imaging Group, CIC biomaGUNE, San Sebastian, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1007\/s00259-013-2534-4","volume":"41","author":"Abikhzer G.","year":"2014","unstructured":"Abikhzer G.; Keidar Z.; SPECT\/CT and tumour imaging. Eur J Nucl Med Mol Imaging 2014,41(Suppl. 1),S67-S80","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4471-2945-5","author":"Heller G.V.","year":"2013","unstructured":"Heller G.V.; Hendel R.C.; Handbook of nuclear cardiology: Cardiac SPECT and cardiac PET 2013"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2174\/1874471007666140821152401","volume":"7","author":"Ciarmiello A.","year":"2014","unstructured":"Ciarmiello A.; Giovannini E.; Meniconi M.; Cuccurullo V.; Gaeta M.C.; Hybrid SPECT\/CT imaging in neurology. Curr Radiopharm 2014,7(1),5-11","journal-title":"Curr Radiopharm"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s40336-014-0092-9","volume":"2","author":"Erba P.A.","year":"2014","unstructured":"Erba P.A.; Israel O.; SPECT\/CT in infection and inflammation. Clin Transl Imaging 2014,2(6),519-535","journal-title":"Clin Transl Imaging"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0893-133X(02)00304-4","volume":"27","author":"Yokoi F.","year":"2002","unstructured":"Yokoi F.; Grunder G.; Biziere K.; Stephane M.; Dogan A.S.; Dannals R.F.; Ravert H.; Suri A.; Bramer S.; Wong D.F.; Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [C]raclopride. Neuropsychopharmacology 2002,27(2),248-259","journal-title":"Neuropsychopharmacology"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/BF02244926","volume":"112","author":"Bench C.J.","year":"1993","unstructured":"Bench C.J.; Lammertsma A.A.; Dolan R.J.; Grasby P.M.; Warrington S.J.; Gunn K.; Cuddigan M.; Turton D.J.; Osman S.; Frackowiak R.S.; Dose dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88,059-01: a study using positron emission tomography and 11C-raclopride. Psychopharmacology (Berl) 1993,112(2-3),308-314","journal-title":"Psychopharmacology (Berl)"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1056\/NEJM200104053441404","volume":"344","author":"Joensuu H.","year":"2001","unstructured":"Joensuu H.; Roberts P.J.; Sarlomo-Rikala M.; Andersson L.C.; Tervahartiala P.; Tuveson D.; Silberman S.; Capdeville R.; Dimitrijevic S.; Druker B.; Demetri G.D.; Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001,344(14),1052-1056","journal-title":"N Engl J Med"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1200\/JCO.2003.05.186","volume":"21","author":"Anderson H.L.","year":"2003","unstructured":"Anderson H.L.; Yap J.T.; Miller M.P.; Robbins A.; Jones T.; Price P.M.; Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate. J Clin Oncol 2003,21(15),2823-2830","journal-title":"J Clin Oncol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00259-004-1633-7","volume":"32","author":"Goerres G.W.","year":"2005","unstructured":"Goerres G.W.; Stupp R.; Barghouth G.; Hany T.F.; Pestalozzi B.; Dizendorf E.; Schnyder P.; Luthi F.; von Schulthess G.K.; Leyvraz S.; The value of PET, CT and inline PET\/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate. Eur J Nucl Med Mol Imaging 2005,32(2),153-162","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=10","first-page":"919","volume":"47","author":"Catafau A.M.","year":"2006","unstructured":"Catafau A.M.; Danus M.; Bullich S.; Llop J.; Perich J.; Cunningham V.J.; Plaza P.; Penengo M.M.; Eersels J.L.; Squassante L.; Ros D.; Barbanoj M.; Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 1-pseudoequilibrium interval and quantification methods. J Nucl Med 2006,47(6),919-928","journal-title":"J Nucl Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1365-2125.2011.04085.x","volume":"73","author":"Matthews P.M.","year":"2012","unstructured":"Matthews P.M.; Rabiner E.A.; Passchier J.; Gunn R.N.; Positron emission tomography molecular imaging for drug development. Br J Clin Pharmacol 2012,73(2),175-186","journal-title":"Br J Clin Pharmacol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/jnc.13454","volume":"136","author":"G\u00f3mez-Vallejo V.","year":"2016","unstructured":"G\u00f3mez-Vallejo V.; Ugarte A.; Garc\u00eda-Barroso C.; Cuadrado-Tejedor M.; Szczupak B.; Dopeso-Reyes I.G.; Lanciego J.L.; Garc\u00eda-Osta A.; Llop J.; Oyarzabal J.; Franco R.; Pharmacokinetic investigation of sildenafil using positron emission tomography and determination of its effect on cerebrospinal fluid cGMP levels. J Neurochem 2016,136(2),403-415","journal-title":"J Neurochem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1016\/j.apradiso.2012.05.020","volume":"70","author":"Gomez-Vallejo V.","year":"2012","unstructured":"Gomez-Vallejo V.; Martin A.; Aginagalde M.; San Sebastian E.; Padro D.; Cossio F.P.; Llop J.; Biodistribution and metabolism of 11C-labeled Kendine 91 in mice and rats. Appl Radiat Isot 2012,70(10),2545-2551","journal-title":"Appl Radiat Isot"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"26077","DOI":"10.1038\/srep26077","volume":"6","author":"Brunetti J.","year":"2016","unstructured":"Brunetti J.; Falciani C.; Roscia G.; Pollini S.; Bindi S.; Scali S.; Arrieta U.C.; G\u00f3mez-Vallejo V.; Quercini L.; Ibba E.; Prato M.; Rossolini G.M.; Llop J.; Bracci L.; Pini A.; \n                        In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate. Sci Rep 2016,6,26077","journal-title":"Sci Rep"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1021\/acs.bioconjchem.7b00325","volume":"28","author":"Heskamp S.","year":"2017","unstructured":"Heskamp S.; Raav\u00e9 R.; Boerman O.; Rijpkema M.; Goncalves V.; Denat F.; \n                        Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art Zr Radiochemistry. Bioconjug Chem 2017,28(9),2211-2223","journal-title":"Bioconjug Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2967\/jnumed.115.162024","volume":"57","author":"Keyaerts M.","year":"2016","unstructured":"Keyaerts M.; Xavier C.; Heemskerk J.; Devoogdt N.; Everaert H.; Ackaert C.; Vanhoeij M.; Duhoux F.P.; Gevaert T.; Simon P.; Schallier D.; Fontaine C.; Vaneycken I.; Vanhove C.; De Greve J.; Lamote J.; Caveliers V.; Lahoutte T.; Phase I.; Study of 68Ga-HER2- Nanobody for PET\/CT Assessment of HER2 Expression in Breast Carcinoma. J Nucl Med 2016,57(1),27-33","journal-title":"J Nucl Med"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.nucmedbio.2016.01.002","volume":"43","author":"Xavier C.","year":"2016","unstructured":"Xavier C.; Blykers A.; Vaneycken I.; D\u2019Huyvetter M.; Heemskerk J.; Lahoutte T.; Devoogdt N.; Caveliers V.; (18)F-nanobody for PET imaging of HER2 overexpressing tumors. Nucl Med Biol 2016,43(4),247-252","journal-title":"Nucl Med Biol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"6293","DOI":"10.1039\/C5TB01157D","volume":"3","author":"Llop J.","year":"2015","unstructured":"Llop J.; Jiang P.; Marradi M.; G\u00f3mez-Vallejo V.; Echeverr\u00eda M.; Yu S.; Puigivila M.; Baz Z.; Szczupak B.; P\u00e9rez-Campa\u00f1a C.; Mao Z.; Gao C.; Moya S.E.; Visualisation of dual radiolabelled poly(lactide-co- glycolide) nanoparticle degradation in vivo using energy- discriminant SPECT. J Mater Chem B Mater Biol Med 2015,3(30),6293-6300","journal-title":"J Mater Chem B Mater Biol Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"BIO88","DOI":"10.1167\/iovs.17-21809","volume":"58","author":"Lauwen S.","year":"2017","unstructured":"Lauwen S.; de Jong E.K.; Lefeber D.J.; den Hollander A.I.; Omics biomarkers in ophthalmology. Invest Ophthalmol Vis Sci 2017,58(6),BIO88-BIO98","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/00003072-199101000-00005","volume":"16","author":"Gr\u00fcnwald F.","year":"1991","unstructured":"Gr\u00fcnwald F.; Zierz S.; Broich K.; Dewes W.; B\u00f6ker T.; Biersack H.J.; Brain SPECT imaging with Tc-99m HMPAO in ophthalmoplegia plus. Clin Nucl Med 1991,16(1),20-23","journal-title":"Clin Nucl Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/WNR.0b013e32831d7f82","volume":"20","author":"Imamura K.","year":"2009","unstructured":"Imamura K.; Onoe H.; Shimazawa M.; Nozaki S.; Wada Y.; Kato K.; Nakajima H.; Mizuma H.; Onoe K.; Taniguchi T.; Sasaoka M.; Hara H.; Tanaka S.; Araie M.; Watanabe Y.; Molecular imaging reveals unique degenerative changes in experimental glaucoma. Neuroreport 2009,20(2),139-144","journal-title":"Neuroreport"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1038\/sj.jcbfm.9600500","volume":"27","author":"Rojas S.","year":"2007","unstructured":"Rojas S.; Mart\u00edn A.; Arranz M.J.; Pareto D.; Purroy J.; Verdaguer E.; Llop J.; G\u00f3mez V.; Gispert J.D.; Mill\u00e1n O.; Chamorro A.; Planas A.M.; Imaging brain inflammation with [(11)C]PK11195 by PET and induction of the peripheral-type benzodiazepine receptor after transient focal ischemia in rats. J Cereb Blood Flow Metab 2007,27(12),1975-1986","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000081205","volume":"36","author":"Wang W.F.","year":"2004","unstructured":"Wang W.F.; Ishiwata K.; Kiyosawa M.; Kawamura K.; Oda K.; Matsuno K.; Kobayashi T.; Mochizuki M.; Investigation of the use of positron emission tomography for neuroreceptor imaging in rabbit eyes. Ophthalmic Res 2004,36(5),255-263","journal-title":"Ophthalmic Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"5899","DOI":"10.1167\/iovs.10-6862","volume":"52","author":"Christoforidis J.B.","year":"2011","unstructured":"Christoforidis J.B.; Carlton M.M.; Knopp M.V.; Hinkle G.H.; PET\/CT imaging of I-124-radiolabeled bevacizumab and ranibizumab after intravitreal injection in a rabbit model. Invest Ophthalmol Vis Sci 2011,52(8),5899-5903","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11095-014-1456-6","volume":"32","author":"Subrizi A.","year":"2015","unstructured":"Subrizi A.; Toropainen E.; Ramsay E.; Airaksinen A.J.; Kaarniranta K.; Urtti A.; Oxidative stress protection by exogenous delivery of rhHsp70 chaperone to the retinal pigment epithelium (RPE), a possible therapeutic strategy against RPE degeneration. Pharm Res 2015,32(1),211-221","journal-title":"Pharm Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1167\/iovs.16-20766","volume":"58","author":"Fern\u00e1ndez-Ferreiro A.","year":"2017","unstructured":"Fern\u00e1ndez-Ferreiro A.; Silva-Rodr\u00edguez J.; Otero-Espinar F.J.; Gonz\u00e1lez-Barcia M.; Lamas M.J.; Ruibal A.; Luaces-Rodriguez A.; Vieites-Prado A.; Sobrino T.; Herranz M.; Garc\u00eda-Varela L.; Blanco-Mendez J.; Gil-Mart\u00ednez M.; Pardo M.; Moscoso A.; Med\u00edn-Aguerre S.; Pardo-Montero J.; Aguiar P.; Positron emission tomography for the development and characterization of corneal permanence of ophthalmic pharmaceutical formulations. Invest Ophthalmol Vis Sci 2017,58(2),772-780","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1167\/iovs.17-21812","volume":"58","author":"Fern\u00e1ndez-Ferreiro A.","year":"2017","unstructured":"Fern\u00e1ndez-Ferreiro A.; Luaces-Rodr\u00edguez A.; Aguiar P.; Pardo-Montero J.; Gonz\u00e1lez-Barcia M.; Garc\u00eda-Varela L.; Herranz M.; Silva-Rodr\u00edguez J.; Gil-Mart\u00ednez M.; Berm\u00fadez M.A.; Vieites-Prado A.; Blanco-M\u00e9ndez J.; Lamas M.J.; G\u00f3mez-Ulla F.; Ruibal \u00c1.; Otero-Espinar F.J.; Gonz\u00e1lez F.; Preclinical PET Study of intravitreal injections. Invest Ophthalmol Vis Sci 2017,58(7),2843-2851","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1007\/s11307-016-1040-z","volume":"19","author":"Keller T.","year":"2017","unstructured":"Keller T.; Krzyczmonik A.; Forsback S.; Picon F.R.L.; Kirjavainen A.K.; Takkinen J.; Rajander J.; Cacheux F.; Damont A.; Dolle F.; Rinne J.O.; Haaparanta-Solin M.; Solin O.; Radiosynthesis and preclinical evaluation of [(18)F]F-DPA, a novel pyrazolo[1,5a]pyrimidine acetamide TSPO radioligand, in healthy sprague dawley Rats. Mol Imaging Biol 2017,19(5),736-745","journal-title":"Mol Imaging Biol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1021\/ja109203d","volume":"133","author":"Qu W.","year":"2011","unstructured":"Qu W.; Zha Z.; Ploessl K.; Lieberman B.P.; Zhu L.; Wise D.R.; Thompson C.B.; Kung H.F.; Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors. J Am Chem Soc 2011,133(4),1122-1133","journal-title":"J Am Chem Soc"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s11011-018-0282-7","volume":"33","author":"Luo S.","year":"2018","unstructured":"Luo S.; Kong X.; Wu J.R.; Wang C.Y.; Tian Y.; Zheng G.; Su Y.Y.; Lu G.M.; Zhang L.J.; Yang G.F.; Neuroinflammation in acute hepatic encephalopathy rats: imaging and therapeutic effectiveness evaluation using (11)C-PK11195 and (18)F-DPA-714 micro-positron emission tomography. Metab Brain Dis 2018,33(5),1733-1742","journal-title":"Metab Brain Dis"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12974-018-1080-1","volume":"15","author":"Hoehne A.","year":"2018","unstructured":"Hoehne A.; James M.L.; Alam I.S.; Ronald J.A.; Schneider B.; D\u2019Souza A.; Witney T.H.; Andrews L.E.; Cropper H.C.; Behera D.; Gowrishankar G.; Ding Z.; Wyss-Coray T.; Chin F.T.; Biswal S.; Gambhir S.S.; [F]FSPG-PET reveals increased cystine\/glutamate antiporter (xc-) activity in a mouse model of multiple sclerosis. J Neuroinflammation 2018,15(1),55","journal-title":"J Neuroinflammation"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.7150\/thno.15616","volume":"6","author":"Domercq M.","year":"2016","unstructured":"Domercq M.; Szczupak B.; Gejo J.; G\u00f3mez-Vallejo V.; Padro D.; Gona K.B.; Doll\u00e9 F.; Higuchi M.; Matute C.; Llop J.; Mart\u00edn A.; PET Imaging with [(18)F]FSPG evidences the role of system xc(-) on brain inflammation following cerebral ischemia in rats. Theranostics 2016,6(11),1753-1767","journal-title":"Theranostics"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13550-018-0400-x","volume":"8","author":"Miyajima N.","year":"2018","unstructured":"Miyajima N.; Ito M.; Rokugawa T.; Iimori H.; Momosaki S.; Omachi S.; Shimosegawa E.; Hatazawa J.; Abe K.; Detection of neuroinflammation before selective neuronal loss appearance after mild focal ischemia using [F]DPA-714 imaging. EJNMMI Res 2018,8(1),43","journal-title":"EJNMMI Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1002\/glia.23326","volume":"66","author":"Col\u00e1s L.","year":"2018","unstructured":"Col\u00e1s L.; Domercq M.; Ramos-Cabrer P.; Palma A.; G\u00f3mez-Vallejo V.; Padro D.; Plaza-Garc\u00eda S.; Pulagam K.R.; Higuchi M.; Matute C.; Llop J.; Mart\u00edn A.; \n                        In vivo imaging of A7 nicotinic receptors as a novel method to monitor neuroinflammation after cerebral ischemia. Glia 2018,66(8),1611-1624","journal-title":"Glia"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.7150\/thno.24128","volume":"8","author":"Zinnhardt B.","year":"2018","unstructured":"Zinnhardt B.; Wiesmann M.; Honold L.; Barca C.; Sch\u00e4fers M.; Kiliaan A.J.; Jacobs A.H.; \n                        In vivo imaging biomarkers of neuroinflammation in the development and assessment of stroke therapies - towards clinical translation. Theranostics 2018,8(10),2603-2620","journal-title":"Theranostics"},{"key":"ref=36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148628","volume":"11","author":"Mittra E.S.","year":"2016","unstructured":"Mittra E.S.; Koglin N.; Mosci C.; Kumar M.; Hoehne A.; Keu K.V.; Iagaru A.H.; Mueller A.; Berndt M.; Bullich S.; Friebe M.; Schmitt-Willich H.; Gekeler V.; Fels L.M.; Bacher-Stier C.; Moon D.H.; Chin F.T.; Stephens A.W.; Dinkelborg L.M.; Gambhir S.S.; Pilot preclinical and clinical evaluation of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate (18F-FSPG) for PET\/CT imaging of intracranial malignancies. PLoS One 2016,11(2)","journal-title":"PLoS One"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11306-015-0877-5","volume":"12","author":"Paris L.P.","year":"2016","unstructured":"Paris L.P.; Johnson C.H.; Aguilar E.; Usui Y.; Cho K.; Hoang L.T.; Feitelberg D.; Benton H.P.; Westenskow P.D.; Kurihara T.; Trombley J.; Tsubota K.; Ueda S.; Wakabayashi Y.; Patti G.J.; Ivanisevic J.; Siuzdak G.; Friedlander M.; Global metabolomics reveals metabolic dysregulation in ischemic retinopathy. Metabolomics 2016,12,15","journal-title":"Metabolomics"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"8084","DOI":"10.1039\/C7NJ00568G","volume":"41","author":"Joshi S.M.","year":"2017","unstructured":"Joshi S.M.; Mane R.B.; Pulagam K.R.; Gomez-Vallejo V.; Llop J.; Rode C.; The microwave-assisted synthesis of 5-substituted 1: H -tetrazoles via [3+2] cycloaddition over a heterogeneous Cu-based catalyst: Application to the preparation of13N-labelled tetrazoles. New J Chem 2017,41(16),8084-8091","journal-title":"New J Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"109633","DOI":"10.1039\/C6RA24670B","volume":"6","author":"Joshi S.M.","year":"2016","unstructured":"Joshi S.M.; G\u00f3mez-Vallejo V.; Salinas V.; Llop J.; Synthesis of13N-labelled polysubstituted triazoles: via Huisgen cycloaddition. RSC Advances 2016,6(111),109633-109638","journal-title":"RSC Advances"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"8954","DOI":"10.1039\/C5CC01913C","volume":"51","author":"Joshi S.M.","year":"2015","unstructured":"Joshi S.M.; de C\u00f3zar A.; G\u00f3mez-Vallejo V.; Koziorowski J.; Llop J.; Coss\u00edo F.P.; Synthesis of radiolabelled aryl azides from diazonium salts: experimental and computational results permit the identification of the preferred mechanism. Chem Commun (Camb) 2015,51(43),8954-8957","journal-title":"Chem Commun (Camb)"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s11307-013-0708-x","volume":"16","author":"Gaja V.","year":"2014","unstructured":"Gaja V.; G\u00f3mez-Vallejo V.; Puigivila M.; P\u00e9rez- Campa\u00f1a, C.; Martin, A.; Garc\u00eda-Osta, A.; Calvo- Fern\u00e1ndez, T.; Cuadrado-Tejedor, M.; Franco, R.; Llop, J. Synthesis and evaluation of (13)N-labelled azo compounds for \u03b2-amyloid imaging in mice. Mol Imaging Biol 2014,16(4),538-549","journal-title":"Mol Imaging Biol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.neuroscience.2012.03.050","volume":"213","author":"Mart\u00edn A.","year":"2012","unstructured":"Mart\u00edn A.; San Sebasti\u00e1n E.; G\u00f3mez-Vallejo V.; Llop J.; Positron emission tomograghy with [N]ammonia evidences long-term cerebral hyperperfusion after 2h-transient focal ischemia. Neuroscience 2012,213,47-53","journal-title":"Neuroscience"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"13619","DOI":"10.1002\/chem.201602471","volume":"22","author":"da Silva E.S.","year":"2016","unstructured":"da Silva E.S.; G\u00f3mez-Vallejo V.; Baz Z.; Llop J.; L\u00f3pez-Gallego F.; Efficient enzymatic preparation of (13) N-labelled amino acids: towards multipurpose synthetic systems. Chemistry 2016,22(38),13619-13626","journal-title":"Chemistry"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1039\/C5CY00179J","volume":"5","author":"Da Silva E.S.","year":"2015","unstructured":"Da Silva E.S.; G\u00f3mez-Vallejo V.; Llop J.; L\u00f3pez-Gallego F.; Efficient nitrogen-13 radiochemistry catalyzed by a highly stable immobilized biocatalyst. Catal Sci Technol 2015,5(5),2705-2713","journal-title":"Catal Sci Technol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/jlcr.3163","volume":"57","author":"G\u00f3mez-Vallejo V.","year":"2014","unstructured":"G\u00f3mez-Vallejo V.; Gaja V.; Gona K.B.; Llop J.; Nitrogen-13: historical review and future perspectives. J Labelled Comp Radiopharm 2014,57(4),244-254","journal-title":"J Labelled Comp Radiopharm"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"8998","DOI":"10.1002\/anie.200800222","volume":"47","author":"Miller P.W.","year":"2008","unstructured":"Miller P.W.; Long N.J.; Vilar R.; Gee A.D.; Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography. Angew Chem Int Ed Engl 2008,47(47),8998-9033","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.2174\/13892029113149990101","volume":"17","author":"Oleksiy I.","year":"2013","unstructured":"Oleksiy I.; Vanessa G-V.; Jordi L.; Jacek K.; On 11C chemistry reviews - surveying and filling the gaps. Curr Org Chem 2013,17(19),2067-2096","journal-title":"Curr Org Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/0020-708X(75)90057-5","volume":"26","author":"Christman D.R.","year":"1975","unstructured":"Christman D.R.; Finn R.D.; Karlstrom K.I.; Wolf A.P.; The production of ultra high activity 11C-labeled hydrogen cyanide, carbon dioxide, carbon monoxide and methane via the 14N(p, \u03b1)11C reaction (XV). Int J Appl Radiat Isot 1975,26(8),435-442","journal-title":"Int J Appl Radiat Isot"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/jlcr.1024","volume":"49","author":"Le Bars D.","year":"2006","unstructured":"Le Bars D.; Malleval M.; Bonnefoi F.; Tourvieille C.; Simple synthesis of [1-11C]acetate. J Labelled Comp Radiopharm 2006,49(3),263-267","journal-title":"J Labelled Comp Radiopharm"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/0883-2889(92)90012-4","volume":"43","author":"Jewett D.M.","year":"1992","unstructured":"Jewett D.M.; A simple synthesis of [11C]methyl triflate. Int J Rad Appl Instrum [A] 1992,43(11),1383-1385","journal-title":"Int J Rad Appl Instrum [A]"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1039\/b515215a","volume":"4","author":"Hosoya T.","year":"2006","unstructured":"Hosoya T.; Sumi K.; Doi H.; Wakao M.; Suzuki M.; Rapid methylation on carbon frameworks useful for the synthesis of 11CH3-incorporated PET tracers: Pd(0)-mediated rapid coupling of methyl iodide with an alkenyltributylstannane leading to a 1-methylalkene. Org Biomol Chem 2006,4(3),410-415","journal-title":"Org Biomol Chem"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"11326","DOI":"10.1039\/c3cc47203e","volume":"49","author":"Kealey S.","year":"2013","unstructured":"Kealey S.; Passchier J.; Huiban M.; Negishi coupling reactions as a valuable tool for [11C]methyl-arene formation; first proof of principle. Chem Commun (Camb) 2013,49(96),11326-11328","journal-title":"Chem Commun (Camb)"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1039\/B510286C","author":"Huiban M.","year":"2006","unstructured":"Huiban M.; Huet A.; Barr\u00e9 L.; Sobrio F.; Fouquet E.; Perrio C.; Methyl transfer reaction from monomethyltin reagent under palladium(0) catalysis: a versatile method for labelling with carbon-11. Chem Commun (Camb) 2006(1),97-99","journal-title":"Chem Commun (Camb)"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1039\/C8CC01540F","volume":"54","author":"Rejc L.","year":"2018","unstructured":"Rejc L.; G\u00f3mez-Vallejo V.; Alc\u00e1zar J.; Alonso N.; Andr\u00e9s J.I.; Arrieta A.; Coss\u00edo F.P.; Llop J.; Negishi coupling reactions with [C]CHI: a versatile method for efficient C-C bond formation. Chem Commun (Camb) 2018,54(35),4398-4401","journal-title":"Chem Commun (Camb)"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S0969-8043(97)00109-7","volume":"48","author":"Zeisler S.K.","year":"1997","unstructured":"Zeisler S.K.; Nader M.; Theobald A.; Oberdorfer F.; Conversion of no-carrier-added [11C]carbon dioxide to [11C]carbon monoxide on molybdenum for the synthesis of 11C-labelled aromatic ketones. Appl Radiat Isot 1997,48(8),1091-1095","journal-title":"Appl Radiat Isot"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1002\/ejoc.200500269","author":"Itsenko O.","year":"2005","unstructured":"Itsenko O.; Kihlberg T.; L\u00e5ngstr\u00f6m B.; Synthesis of aliphatic [carbonyl-11C]esters using [11C]carbon monoxide. Eur J Org Chem 2005(17),3830-3834","journal-title":"Eur J Org Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1002\/ejoc.200200586","author":"Karimi F.","year":"2003","unstructured":"Karimi F.; Langstr\u00f6m B.; Synthesis of11C-labelled amides by palladium-mediated carboxamination using [11C]carbon monoxide, in situ activated amines and 1,2,2,6,6- pentamethylpiperidine. Eur J Org Chem 2003(11),2132-2137","journal-title":"Eur J Org Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1002\/ejoc.200400038","author":"Rahman O.","year":"2004","unstructured":"Rahman O.; Llop J.; L\u00e5ngstr\u00f6m B.; Organic bases as additives to improve the radiochemical yields of [ 11C]ketones prepared by the Suzuki coupling reaction. Eur J Org Chem 2004(12),2674-2678","journal-title":"Eur J Org Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/jlcr.2930","volume":"55","author":"Eriksson J.","year":"2012","unstructured":"Eriksson J.; Van Den Hoek J.; Windhorst A.D.; Transition metal mediated synthesis using [11C]CO at low pressure - a simplified method for 11C-carbonylation. J Labelled Comp Radiopharm 2012,55(6),223-228","journal-title":"J Labelled Comp Radiopharm"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1039\/b314982j","author":"Audrain H.","year":"2004","unstructured":"Audrain H.; Martarello L.; Gee A.; Bender D.; Utilisation of [11C]-labelled boron carbonyl complexes in palladium carbonylation reaction. Chem Commun (Camb) 2004(5),558-559","journal-title":"Chem Commun (Camb)"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/chem.201002644","volume":"17","author":"Miller P.W.","year":"2011","unstructured":"Miller P.W.; Audrain H.; Bender D.; deMello A.J.; Gee A.D.; Long N.J.; Vilar R.; Rapid carbon-11 radiolabelling for PET using microfluidics. Chemistry 2011,17(2),460-463","journal-title":"Chemistry"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0969-8043(94)00111-c","volume":"46","author":"Roberts A.D.","year":"1995","unstructured":"Roberts A.D.; Oakes T.R.; Nickles R.J.; Development of an improved target for [18F]F2 production. Appl Radiat Isot 1995,46(2),87-91","journal-title":"Appl Radiat Isot"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"11491","DOI":"10.1039\/c3cc46695g","volume":"49","author":"Gona K.B.","year":"2013","unstructured":"Gona K.B.; G\u00f3mez-Vallejo V.; Padro D.; Llop J.; [18F]fluorination of o-carborane via nucleophilic substitution: towards a versatile platform for the preparation of 18F-labelled BNCT drug candidates. Chem Commun (Camb) 2013,49(98),11491-11493","journal-title":"Chem Commun (Camb)"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1021\/ol501243g","volume":"16","author":"Ichiishi N.","year":"2014","unstructured":"Ichiishi N.; Brooks A.F.; Topczewski J.J.; Rodnick M.E.; Sanford M.S.; Scott P.J.; Copper-catalyzed [18F]fluorination of (mesityl)(aryl)iodonium salts. Org Lett 2014,16(12),3224-3227","journal-title":"Org Lett"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S0969-8051(97)00078-4","volume":"24","author":"Bergman J.","year":"1997","unstructured":"Bergman J.; Solin O.; Fluorine-18-labeled fluorine gas for synthesis of tracer molecules. Nucl Med Biol 1997,24(7),677-683","journal-title":"Nucl Med Biol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/jlcr.2580250912","volume":"25","author":"Oberdorfer F.","year":"1988","unstructured":"Oberdorfer F.; Hofmann E.; Maier\u2010Borst W.; Preparation of 18F-labelled N\u2010fluoropyridinium triflate. J Labelled Comp Radiopharm 1988,25(9),999-1005","journal-title":"J Labelled Comp Radiopharm"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/0883-2889(90)90020-h","volume":"41","author":"Satyamurthy N.","year":"1990","unstructured":"Satyamurthy N.; Bida G.T.; Phelps M.E.; Barrio J.R.N.; [18F]fluoro-N-alkylsulfonamides: Novel reagents for mild and regioselective radiofluorination. Int J Rad Appl Instrum [A] 1990,41(8),733-738","journal-title":"Int J Rad Appl Instrum [A]"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"6821","DOI":"10.1002\/anie.201002310","volume":"49","author":"Teare H.","year":"2010","unstructured":"Teare H.; Robins E.G.; Kirjavainen A.; Forsback S.; Sandford G.; Solin O.; Luthra S.K.; Gouverneur V.; Radiosynthesis and evaluation of [18F]selectfluor bis(triflate). Angew Chem Int Ed Engl 2010,49(38),6821-6824","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/bc500475e","volume":"26","author":"Jacobson O.","year":"2015","unstructured":"Jacobson O.; Kiesewetter D.O.; Chen X.; Fluorine-18 radiochemistry, labeling strategies and synthetic routes. Bioconjug Chem 2015,26(1),1-18","journal-title":"Bioconjug Chem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/0020-708X(77)90132-6","volume":"28","author":"Kondo K.","year":"1977","unstructured":"Kondo K.; Lambrecht R.M.; Wolf A.P.; Iodine-123 production for radiopharmaceuticals--XX excitation functions of the 124Te(p, 2n)123I and 124Te(p, n)124I reactions and the effect of target enrichment on radionuclidic purity. Int J Appl Radiat Isot 1977,28(4),395-401","journal-title":"Int J Appl Radiat Isot"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0168-9002(91)90773-J","volume":"303","author":"Clem R.G.","year":"1991","unstructured":"Clem R.G.; Lambrecht R.M.; Enriched 124Te targets for production of 123I and 124I. Nucl Instrum Methods Phys Res A 1991,303(1),115-118","journal-title":"Nucl Instrum Methods Phys Res A"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0969-8043(94)00145-P","volume":"46","author":"Scholten B.","year":"1995","unstructured":"Scholten B.; Kov\u00e1cs Z.; T\u00e1rk\u00e1nyi F.; Qaim S.M.; Excitation functions of 124Te(p, xn)124,123I reactions from 6 to 31 MeV with special reference to the production of 124I at a small cyclotron. Appl Radiat Isot 1995,46(4),255-259","journal-title":"Appl Radiat Isot"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0168-9002(89)90155-1","volume":"282","author":"Qaim S.M.","year":"1989","unstructured":"Qaim S.M.; Target development for medical radioisotope production at a cyclotron. Nucl Instrum Methods Phys Res A 1989,282(1),289-295","journal-title":"Nucl Instrum Methods Phys Res A"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/BF02163571","volume":"213","author":"Weinreich R.","year":"1996","unstructured":"Weinreich R.; Knust J.; Quality assurance of iodine-124 produced via the nuclear reaction 124Te (d, 2n)124I. J Radioanal Nucl Chem 1996,213,253-261","journal-title":"J Radioanal Nucl Chem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/194495a0","volume":"194","author":"Hunter W.M.","year":"1962","unstructured":"Hunter W.M.; Greenwood F.C.; Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 1962,194,495-496","journal-title":"Nature"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/0006-291X(78)91322-0","volume":"80","author":"Fraker P.J.","year":"1978","unstructured":"Fraker P.J.; Speck J.C.; Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun 1978,80(4),849-857","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1042\/bj1330529","volume":"133","author":"Bolton A.E.","year":"1973","unstructured":"Bolton A.E.; Hunter W.M.; The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Biochem J 1973,133(3),529-539","journal-title":"Biochem J"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1006\/abio.1996.0317","volume":"239","author":"Breslav M.","year":"1996","unstructured":"Breslav M.; McKinney A.; Becker J.M.; Naider F.; Preparation of radiolabeled peptides via an iodine exchange reaction. Anal Biochem 1996,239(2),213-217","journal-title":"Anal Biochem"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s10967-009-0051-5","volume":"281","author":"Dutta B.","year":"2009","unstructured":"Dutta B.; Maiti M.; Lahiri S.; Production of 88,89Zr by proton induced activation ofnatY and separation by SLX and LLX. J Radioanal Nucl Chem 2009,281(3),663-667","journal-title":"J Radioanal Nucl Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0003-2670(00)80351-7","volume":"219","author":"Fadeeva V.I.","year":"1989","unstructured":"Fadeeva V.I.; Tikhomirova T.I.; Yuferova I.B.; Kudryavtsev G.V.; Preparation, properties and analytical application of silica with chemically grafted hydroxamic acid groups. Anal Chim Acta 1989,219(2),201-212","journal-title":"Anal Chim Acta"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.nucmedbio.2009.05.007","volume":"36","author":"Holland J.P.","year":"2009","unstructured":"Holland J.P.; Sheh Y.; Lewis J.S.; Standardized methods for the production of high specific-activity zirconium-89. Nucl Med Biol 2009,36(7),729-739","journal-title":"Nucl Med Biol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/0883-2889(92)90170-j","volume":"43","author":"Meijs W.E.","year":"1992","unstructured":"Meijs W.E.; Herscheid J.D.M.; Haisma H.J.; Pinedo H.M.; Evaluation of desferal as a bifunctional chelating agent for labeling antibodies with Zr-89. Int J Rad Appl Instrum [A] 1992,43(12),1443-1447","journal-title":"Int J Rad Appl Instrum [A]"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1021\/cr900325h","volume":"110","author":"Wadas T.J.","year":"2010","unstructured":"Wadas T.J.; Wong E.H.; Weisman G.R.; Anderson C.J.; Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease. Chem Rev 2010,110(5),2858-2902","journal-title":"Chem Rev"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s00259-016-3499-x","volume":"44","author":"Vugts D.J.","year":"2017","unstructured":"Vugts D.J.; Klaver C.; Sewing C.; Poot A.J.; Adamzek K.; Huegli S.; Mari C.; Visser G.W.M.; Valverde I.E.; Gasser G.; Mindt T.L.; van Dongen G.A.M.S.; Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for Zr-immuno-PET. Eur J Nucl Med Mol Imaging 2017,44(2),286-295","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"11523","DOI":"10.1039\/C4CC05558F","volume":"50","author":"Patra M.","year":"2014","unstructured":"Patra M.; Bauman A.; Mari C.; Fischer C.A.; Blacque O.; H\u00e4ussinger D.; Gasser G.; Mindt T.L.; An octadentate bifunctional chelating agent for the development of stable zirconium-89 based molecular imaging probes. Chem Commun (Camb) 2014,50(78),11523-11525","journal-title":"Chem Commun (Camb)"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1136\/bjo.2005.073700","volume":"89","author":"Prydal J.I.","year":"2005","unstructured":"Prydal J.I.; Jenkins D.R.; Lovering A.; Watts A.; The pharmacokinetics of linezolid in the non-inflamed human eye. Br J Ophthalmol 2005,89(11),1418-1419","journal-title":"Br J Ophthalmol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.1167\/iovs.11-8417","volume":"53","author":"Saleh M.","year":"2012","unstructured":"Saleh M.; Lef\u00e8vre S.; Acar N.; Bourcier T.; Marcellin L.; Pr\u00e9vost G.; Subilia A.; Gaucher D.; Jehl F.; Efficacy of intravitreal administrations of linezolid in an experimental model of S.aureus-related endophthalmitis. Invest Ophthalmol Vis Sci 2012,53(8),4832-4841","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/00006982-199911000-00013","volume":"19","author":"Hegazy H.M.","year":"1999","unstructured":"Hegazy H.M.; Kivilcim M.; Peyman G.A.; Unal M.H.; Liang C.; Molinari L.C.; Kazi A.A.; Evaluation of toxicity of intravitreal ceftazidime, vancomycin, and ganciclovir in a silicone oil-filled eye. Retina 1999,19(6),553-557","journal-title":"Retina"},{"key":"ref=89","first-page":"502","volume":"31","author":"Ficker L.","year":"1990","unstructured":"Ficker L.; Meredith T.A.; Gardner S.; Wilson L.A.; Cefazolin levels after intravitreal injection. Effects of inflammation and surgery. Invest Ophthalmol Vis Sci 1990,31(3),502-505","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=90","first-page":"307","volume":"22","author":"Fiscella R.","year":"1987","unstructured":"Fiscella R.; Peyman G.A.; Fishman P.H.; Duration of therapeutic levels of intravitreally injected liposome-encapsulated clindamycin in the rabbit. Can J Ophthalmol 1987,22(6),307-309","journal-title":"Can J Ophthalmol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ejmech.2016.05.019","volume":"120","author":"El Aissi R.","year":"2016","unstructured":"El Aissi R.; Miladi I.; Chezal J.M.; Chavignon O.; Miot-Noirault E.; Moreau E.; Melanoma-targeted delivery system (part 2): Synthesis, radioiodination and biological evaluation in B16F0 bearing mice. Eur J Med Chem 2016,120,304-312","journal-title":"Eur J Med Chem"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1039\/p19960001659","author":"Chambers R.D.","year":"1996","unstructured":"Chambers R.D.; Skinner C.J.; Atherton M.J.; Moilliet J.S.; Elemental fluorine. Part 4. Use of elemental fluorine for the halogenation of aromatics. J Chem Soc, Perkin Trans 1 1996(14),1659-1664","journal-title":"J Chem Soc, Perkin Trans 1"},{"key":"ref=93","author":"Guillemot G. C.","year":"2015","unstructured":"Guillemot G. C.; Barral K.; Canard B.; Querat G.; Alvarez K.; De Llamballerie X. N.; Mahuteau-Betzer F.; Poinsard C.;  Propenamide thiophene derivatives as flavivirus inhibitors and their use 2015","journal-title":"Propenamide thiophene derivatives as flavivirus inhibitors and their use"},{"key":"ref=94","first-page":"219","volume":"3","author":"Chandra Babu K.","year":"2011","unstructured":"Chandra Babu K.; Buchi Reddy R.; Gangaiah L.; Madhusudhan G.; Mukkanti K.; A new and alternate synthesis of Linezolid: an antibacterial agent. Pharma Chem 2011,3(4),219-226","journal-title":"Pharma Chem"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2147\/OPTH.S1666","volume":"2","author":"Miller D.","year":"2008","unstructured":"Miller D.; Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections. Clin Ophthalmol 2008,2(1),77-91","journal-title":"Clin Ophthalmol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.3762\/bjoc.9.265","volume":"9","author":"Baumann M.","year":"2013","unstructured":"Baumann M.; Baxendale I.R.; An overview of the synthetic routes to the best selling drugs containing 6-membered heterocycles. Beilstein J Org Chem 2013,9,2265-2319","journal-title":"Beilstein J Org Chem"},{"key":"ref=97","first-page":"1602","volume":"24","author":"Barza M.","year":"1983","unstructured":"Barza M.; Kane A.; Baum J.; Pharmacokinetics of intravitreal carbenicillin, cefazolin, and gentamicin in rhesus monkeys. Invest Ophthalmol Vis Sci 1983,24(12),1602-1606","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"9099","DOI":"10.1021\/jo971166u","volume":"62","author":"J\u00fastiz O.H.","year":"1997","unstructured":"J\u00fastiz O.H.; Fern\u00e1ndez-Lafuente R.; Guis\u00e1n J.M.; Negri P.; Pagani G.; Pregnolato M.; Terreni M.; One-pot chemoenzymatic synthesis of 3\u2018-functionalized cephalosporines (cefazolin) by three consecutive biotransformations in fully aqueous medium. J Org Chem 1997,62(26),9099-9106","journal-title":"J Org Chem"},{"key":"ref=99","first-page":"186","volume":"20","author":"Li H.","year":"1995","unstructured":"Li H.; Liu Y.; Li J.; Pharmacokinetics and relative bioavailability studies of clindamycin phosphate in healthy volunteers. Chin J Antibiot 1995,20(3),186-189","journal-title":"Chin J Antibiot"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1021\/ja00986a038","volume":"89","author":"Magerlein B.J.","year":"1967","unstructured":"Magerlein B.J.; Birkenmeyer R.D.; Herr R.R.; Kagan F.; Lincomycin. V. Amino acid fragment. J Am Chem Soc 1967,89(10),2459-2464","journal-title":"J Am Chem Soc"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/syn.20703","volume":"64","author":"Saba W.","year":"2010","unstructured":"Saba W.; Valette H.; Peyronneau M.A.; Bramoull\u00e9 Y.; Coulon C.; Curet O.; George P.; Doll\u00e9 F.; Bottlaender M.; [(11)C]SL25.1188, a new reversible radioligand to study the monoamine oxidase type B with PET: preclinical characterisation in nonhuman primate. Synapse 2010,64(1),61-69","journal-title":"Synapse"},{"key":"ref=102","first-page":"18","volume":"59","author":"Van Dongen G.A.M.S.","year":"2015","unstructured":"Van Dongen G.A.M.S.; Huisman M.C.; Boellaard R.; Harry Hendrikse N.; Windhorst A.D.; Visser G.W.M.; Molthoff C.F.M.; Vugts D.J.; 89Zr-immuno-PET for imaging of long circulating drugs and disease targets: why, how and when to be applied? Q J Nucl Med Mol Imaging 2015,59(1),18-38","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fphar.2016.00131","volume":"7","author":"Jauw Y.W.","year":"2016","unstructured":"Jauw Y.W.; Menke-van der Houven van Oordt, C.W.; Hoekstra, O.S.; Hendrikse, N.H.; Vugts, D.J.; Zijlstra, J.M.; Huisman, M.C.; van Dongen, G.A. Immuno-positron emission tomography with zirconium-89-labeled monoclonal antibodies in oncology: what can we learn from initial clinical trials? Front Pharmacol 2016,7,131","journal-title":"Front Pharmacol"},{"key":"ref=104","author":"Mishra K. P.","year":"2015","unstructured":"Mishra K. P.;  Biological responses, monitoring and protection form radiation exposure 2015","journal-title":"Biological responses, monitoring and protection form radiation exposure"},{"key":"ref=105","author":"Belotserkovsky E.","year":"2013","unstructured":"Belotserkovsky E.; Ostaltsov Z.;  Ionizing radiation: Applications, sources and biological effects 2013","journal-title":"Ionizing radiation: Applications, sources and biological effects"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1667\/RR1688.1","volume":"172","author":"Ainsbury E.A.","year":"2009","unstructured":"Ainsbury E.A.; Bouffler S.D.; D\u00f6rr W.; Graw J.; Muirhead C.R.; Edwards A.A.; Cooper J.; Radiation cataractogenesis: a review of recent studies. Radiat Res 2009,172(1),1-9","journal-title":"Radiat Res"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/172343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T11:10:54Z","timestamp":1585393854000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/172343\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,9]]},"references-count":106,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,3,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867326666190530122032","relation":{},"ISSN":["0929-8673"],"issn-type":[{"type":"print","value":"0929-8673"}],"subject":[],"published":{"date-parts":[[2020,3,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-09-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}